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ABSTRACT
While DNA methyltransferase1 (DNMT1) is classic-
ally known for its functions as a maintenance
methyltransferase enzyme, additional roles for
DNMT1 in gene expression are not as clearly under-
stood. Several groups have shown that deletion of
the catalytic domain from DNMT1 does not abolish
repressive activity of the protein against a reporter
gene. In our studies, we examine the repressor
function of catalytically inactive DNMT1 at endogen-
ous genes. First, potential DNMT1 target genes were
identified by searching for genes up-regulated in
HCT116 colon cancer cells genetically disrupted for
DNMT1 (DNMT1
 /  hypomorph cells). Next, the re-
quirement for DNMT1 activity for repression of these
genes was assessed by stably restoring expression
of wild-type or catalytically inactive DNMT1. Both
wild-type and mutant proteins are able to occupy
the promoters and repress the expression of a set
of target genes, and induce, at these promoters,
both the depletion of active histone marks and the
recruitment of a H3K4 demethylase, KDM1A/LSD1.
Together, our findings show that there are genes
for which DNMT1 acts as a transcriptional repressor
independent from its methyltransferase function and
that this repressive function may invoke a role for a
scaffolding function of the protein at target genes.
INTRODUCTION
DNA methyltransferase1 (DNMT1) has been
characterized as a maintenance DNA methyltransferase
enzyme able to catalyze the addition of a methyl group
to cytosines adjacent to guanines (1,2). The protein prefers
hemimethylated substrates (2,3) although studies have
shown it can catalyze methylation of unmethylated sub-
strates as well (4).
Loss of function of DNMT1 in mice causes embryonic
lethality with stunted development starting from Day 9.5
to 10.5 (5) and in xenopus, DNMT1 depletion by antisense
RNA causes the embryos to die during gastrulation and
neurulation (6). Additionally, depletion of DNMT1 in
mouse ﬁbroblasts causes cell apoptosis within 5–6 days of
DNMT1 loss (7) and genetic disruption of DNMT1 in
HCT116 colon cancer cells causes mitotic catastrophe, G2/
Mcell-cyclearrestandeventually,apoptosiswithin48h(8).
Another variant of HCT116 cells that have been genetic-
ally disrupted for exons 3–5 of DNMT1 retain a
hypomorphic DNMT1 protein (9,10). In these cells, an
alternative splice variant is transcribed and translated
yielding a low level of truncated DNMT1 which lacks the
binding sites for PCNA and the corepressor protein,
DMAP, (11) but retains a low level of the active C-terminal
catalytic domain (12). These hypomorphic cells show  90–
95% depletion of DNA methyltransferase activity, but
minimal loss of global DNA methylation (9). The presence
ofthiscatalyticallyactivehypomorphmaypartiallyexplain
whytheseknockoutcelllinessurviveandproliferate(10,12).
However, despite the presence of a truncated DNMT1, a
number of genes have been found to be upregulated in
these cell lines (13). This upregulation may be due to lower
levelsoftruncatedDNMT1butmayalsohintattheimport-
ance of thedeleted domain(s) in gene regulation.
The importance of the N-terminus of DNMT1 was
illustrated, by our lab and others, in three reporter
assays in which, despite the deletion of the C-terminal
catalytic domain of DNMT1, repression of reporter
genes was observed (11,14,15). In these studies, this
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members of the HDAC family, HDAC1 and HDAC2,
and the interaction with these deacetylases resulted in
repression of gene transcription. These ﬁndings illustrated
that the repressive activity of DNMT1 does not solely
depend on the catalytic function of the protein.
Additional evidence suggests that DNMT1 mediated
repression may not only be dependent on DNA methyla-
tion. Closer inspection of our previous performed micro-
array studies (13) reveals that approximately one-third of
the genes upregulated in DNMT1
 /  cells do not contain
dense CpG islands. It has also been shown that treat-
ment of some cells by a DNMT1 inhibitor, 5-aza-20-
deoxycytidine (DAC), causes increases in expression of
some genes without evident changes in DNA methylation
(16,17). Since DAC treatment is also known to cause
DNMT1 degradation, (18,19) the repressive ability of
the protein at speciﬁc silenced and unmethylated genes
may be due to a non-catalytic function of DNMT1 poten-
tially associated with additional proteins. To this end, a
number of repressive proteins such as corepressor
DMAP1 (11) as well as histone-modifying enzymes,
HDAC1/2 (11,14,15), G9A (20), SUV39H1 (21), EZH2
(22), HP1a, b and g (23) and KDM1A/LSD1 (24) have
been found to interact with DNMT1.
In our current work, we show that, while the import-
ance of the methyltransferase function of DNMT1 is un-
deniable, gene repression at some endogenous target genes
can occur without need for catalytic activity of the
protein. We provide evidence that a catalytically inactive
DNMT1 can affect some histone modiﬁcations and that
one histone demethylase, LSD1, associates with and is
recruited by both wild-type (wt) and catalytically
inactive DNMT1 to speciﬁc promoters and partially
mediates repression of these genes. The results of this
study suggest that DNMT1 has repressive functions
other than its DNA methyltransferase activity suggesting
scaffolding roles for the protein to recruit other transcrip-
tional repressive complexes.
MATERIALS AND METHODS
Plasmids
wtDNMT1 (NM_001130823.1) and catalytically inactive
DNMT1 (C1226W) with N-terminal FLAG tag inserts
were cloned into a pEF1a IRES-puro vector.
Cell culture
HCT116 and DNMT1
 /  subclone 5F, created previously
(9), were cultured in 5A McCoy’s modiﬁed media using
10% fetal bovine serum. The wt and mutant (mut)
DNMT1 vectors were transfected into DNMT1
 /  cells
using lipofectamine 2000 (invitrogen) and selected using
0.3–0.5mg/ml of puromycin. Puromycin resistant clones
were isolated and expanded and presence of DNMT1
was screened by western blots.
Western blot analysis
For whole-cell extraction of protein, cell pellets were
resuspended in 4% SDS and processed through
QIAshredder (Qiagen). Antibodies utilized in western
blot analysis were as follows: aDNMT1 (Sigma D4567)
1:2000, aDNMT1 (epitomics 2788-1) 1:3000, abactin
(Sigma 5441) 1:10000, aLSD1 (Millipore 09-058)
1:10000, aCBP (Santa Cruz sc-369) 1:1000, aLaminB
(Santa Cruz) 1:2000, a-tubulin (Sigma T6074) 1:10000
and aGAPDH (Millipore) 1:10000. Cytoplasmic and
nuclear extracts were made by resuspending cell pellets
with cytoplasmic extraction buffer: CEBN (10mM
HEPES 7.8, 10mM KCl, 2mM MgCl2, 0.34 M Sucrose,
10% Glycerol, 0.2% NP40/IPEGAL), followed by incu-
bation for 10min on ice with vortexing every minute.
Nuclear pellets were separated from cytoplasmic super-
natant by centrifugation. The nuclear pellets were then
washed once with CEB (10mM HEPES 7.8, 10mM
KCl, 2mM MgCl2, 0.34M Sucrose, 10% Glycerol)
pelleted by centrifugation, resuspended in 4% SDS and
sheared with QIAshredder (Qiagen).
DNMT1 and LSD1 knockdowns
HCT116 cells were transfected with either a non-targeting
control (Dharmacon D-001810-01-05) or DNMT1
(Dharmacon J-004605-06-0005) targeting siRNA and
using Lipofectamine 2000 (Invitrogen). Cells were trans-
fected with 25nM siRNA at 0, 24h, and 48h. Cells were
harvested for analysis at 72h post-transfection. LSD1
knockdowns in HCT116 parent cells and individual
clones E1, wt1, wt2, mut1 and mut2 cells were performed
as follows: The cells were plated to 20% conﬂuency,
infected the next day with lentiviral shRNA targeting
LSD1 (Sigma TRCN0000046072) or non-targeting
control (Sigma SHC002), split 48h later and harvested 5
days post-infection for analysis.
Real-time–PCR
RNA was isolated using the RNeasy kit with on-column
DNaseI treatment (Qiagen) and cDNA was made using
Superscript3 and oligodT20 (Invitrogen). RT–PCR was
performed using the QuantiTect SYBR Green PCR Kit
(Qiagen). bactin or GAPDH was used as the loading
control. Primer sequences used for all studies can be
found in Supplementary Table S1.
Methylation speciﬁc PCR and bisulﬁte sequencing
Genomic DNA was extracted with a lysis buffer contain-
ing 20mmol/l Tris–HCl, 20mmol/l EDTA, 2% SDS and
0.5mg/ml proteinaseK. One microgram of genomic DNA
was subjected to bisulﬁte treatment for subsequent PCR
analyses (25). Methylation-speciﬁc PCR (MSP) was per-
formed as previously described and the products were
visualized on 2% agarose gels (26). Bisulﬁte sequencing
was performed as previously described (27). MSP and
Bisulﬁte sequencing primers are found in Supplementary
Table S1.
Gene-expression microarrays
The mut and empty vector RNA were processed and
quality controlled for microarray analysis as per the
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(limma package, version 3.6.9, in Bioconductor). Median
Log2 ratios of Cy5 (mut) to Cy3 (empty vector) were
computed for all probes mapping to the same gene.
Genes that had a Log2 ratio of at least+0.48 were called
as upregulated while genes with  0.48 Log2 ratios were
called downregulated.
Chromatin Immunoprecipitation
Antibodies used for Chromatin Immunoprecipitation
(ChIP) were as follows: aDNMT1 (Sigma), aFLAG
(Sigma), aH3-K4me2(Millipore), aH3-K4me3 (Millipore),
aH3-K9Ac (Millipore), aH3-K9me2 (Millipore), aH3-
K9me3 (courtesy of Thomas Jenuwein), aH3-K27me3
(Millipore), aLSD1 (Abcam) and aH3 (Abcam). Cells
were crosslinked as previously described (28). Nuclear
extracts from  1 10
6 cells were used per IP. Crosslinked
pellets were resuspended with CEBN. The solution was
incubated on ice for 10min with vortexing every mi-
nute and nuclear pellet was centrifuged at 6400rpm in the
cold for 5min. The nuclear pellets were washed once with
CEB and then resuspended with SDS lysis buffer
(Millipore). Samples were sonicated to 500-bp to 1-kb frag-
ments, 60–80mg of chromatin was used per IP and appro-
priate amounts of antibodies, between 2 and 10mg, were
added to sonicated DNA. Dynal magnetic beads
(Invitrogen) were added for 3h and wash conditions were
adjusted based on the antibodies. IP speciﬁc products were
ampliﬁed using RT–PCR (primers are in Supplementary
Table S1).
Co-immunoprecipitation
To prepare cell extracts, cells were washed with cold PBS,
resuspended in cytoplasmic extract buffer [10mM HEPES
(pH 8), 10mM KCl, 2mM CaCl2, 0.34M sucrose, 10%
Glycerol, 0.2% NP40 and protease inhibitors] and
incubated on ice for 10min. Samples were centrifuged at
4000rpm for 5min at 4 C. The pellet was resuspended in
the cytoplasmic extract buffer once, centrifuged again at
4000rpm for 5min at 4 C, and then resuspended in a
modiﬁed RIPA buffer 1 (50mM Tris pH 7.5, 100mM
NaCl, 3mM EDTA, 0.5% NP40 and protease inhibitors).
The nuclear extract was sonicated for 20 pulses and then
cleared by high speed centrifugation (30min, 14000rpm,
4 C). Nuclear lysates were rotated with Sigma DNMT1
antibody (D4692) or Abcam LSD1 antibody (ab17721)
overnight at 4 C, and we used a rabbit anti-CBP
antibody (SC-583X, Santa Cruz) as the negative control
of the immunoprecipitation. Protein A/G-agarose beads
(Santa Cruz) were added to the samples and samples
were rotated for 3h at 4 C. Then, protein A/G beads
were washed four times with modiﬁed RIPA buffer2
(50mM Tris pH 7.5, 150mM NaCl, 5mM EDTA, 0.5%
NP40, 0.5% TritonX-100 and protein inhibitors) by
rotation for 5min at 4 C. Proteins were extracted from
Protein A/G beads by boiling in 1  LDS gel-loading
buffer.
RESULTS
Deﬁning DNMT1 target genes
Previous work has shown that DNMT1 lacking the cata-
lytic domain represses transcription of a reporter gene.
However, these studies do not resolve whether this
protein can exert such activity on endogenous targets.
Here, we investigate the gene repressive function of
DNMT1 at such targets in the context of native chromatin.
We ﬁrst identiﬁed DNMT1 gene targets using the previ-
ously discussed hypomorph DNMT1
 /  HCT116 cells
(9,10). By examining our previous expression microarray
data for a clone of these cells, we identiﬁed over 1000
genes for which expression was increased in DNMT1
 / 
cells compared to HCT116 cells (13). We reﬁned this list
further by examining the expression proﬁles of three add-
itional subclones of DNMT1
 /  cells. By selecting
genes that were upregulated in all four of these clones we
identiﬁed 229 candidate genes (Figure 1A and
Supplementary Table S2A). Additionally, to characterize
the repressive effects of DNMT1 alone, we also eliminated
genes that were upregulated in DNMT3b
 /  in HCT116
since our previous studies strongly suggested a functional
interaction or cross talk, between DNMT1 and DNMT3b
(29). This reduced the list to 135 genes (Supplementary
Table S2B). From these, we chose 11 genes to validate by
RT–PCR which showed a varying upregulation on the
arrays from high to slight in DNMT1
 /  cells. All genes
analyzed, except POTEB (Supplementary Figure S1),
showed an increase in expression in DNMT1
 /  relative
to HCT116 cells (Figure 1B and Supplementary Figure
S1) while a control gene, cMYC, was not further
upregulated and even decreased slightly (Figure 1B). This
slight decrease in cMYC levels may be due to modestly
slower growth seen in DNMT1
 /  cells (29).
To further validate that the above genes were speciﬁc
targets and not altered due to secondary effects result-
ing from stable knockout of the protein, we employed a
transient siRNA approach to knockdown DNMT1
(Figure 1C) in wt HCT116 cells. We observed increases
in expression of all genes studied including DSCR8,
MAGEA10, TXNIP and DTX3, but not the negative
control cMYC, (Figure 1D) validating the speciﬁcity of the
changes. However, these ﬁndings do not demonstrate if
DNMT1 controls the expression of these genes directly
by binding to the promoter or by secondary, indirect
effects. To further address this issue, we used ChIP to
investigate whether DNMT1 was recruited to these pro-
moters. The speciﬁcity of the antibody for DNMT1
protein was validated by using the DNMT1
 /  cells as
the negative control. At all target genes studied, we
observed localization of DNMT1 above background
levels but not to cMYC (Figure 1E) demonstrating that
these promoters were occupied by DNMT1 and further
suggests that these are direct DNMT1 target genes.
DNMT1 catalytic activity is not required for gene
repression at endogenous targets
We next assessed how the above repression effects of
DNMT1 depend upon the DNA methylation catalytic
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Figure 1. DNMT1 target genes. (A) Venn diagram depicts numbers of genes upregulated in clones containing empty vector pEF1aIRESpuro (E1,
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 /  hypomorphs compared to parental HCT116. ‘DNMT1
 / ’ is the parental DNMT1
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 /  were eliminated and yielded 135 genes. (B) RT–PCR validation for upregulation of genes in DNMT1
 /  (E1) cells. Fold change relative
to HCT116 is calculated. cMYC was used as a negative control for a gene with unchanged expression in the DNMT1
 /  cells. Microarray fold
changes for individual genes are written below. (C) Western blot to assess transient knockdown of DNMT1 in HCT116 cells transfected with
DNMT1 siRNA (DNMT1si) or non-target siRNA (NTsi) for 72h. abactin serves as a loading control. (D) RT–PCR analysis of DSCR8, DTX3,
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Nucleic Acids Research, 2012,Vol.40, No. 10 4337activity of the protein. To do this, wt or a catalytically
inactive DNMT1 (mut), each containing a N-terminus
FLAG tag, were stably expressed with puromycin selec-
tion in the DNMT1
 /  hypomorph cells and compared to
insertion of an empty vector (E) construct. The mut con-
struct contains a single point mutation at amino acid
position 1226 from a cysteine to tryptophan rendering
the protein catalytically inactive (30) but otherwise
preserving the full structure of the protein (Figure 2A).
Individual transfected clones with exogenous wt or mut
DNMT1 protein levels similar to levels of endogenous
DNMT1 in HCT116 were selected for further analysis
(Figure 2B). Additionally, in all clones, exogenous
DNMT1 showed nuclear expression pattern similar to
the parental HCT116 cells (Figure 2C).
We next studied the expression, by RT–PCR, of four
DNMT1 target genes after re-introducing either wt or mut
DNMT1. As expected, DNMT1
 /  hypomorph vector
only clone, E1, has increased expression of all tested
genes (Figure 3A). Restoring wt or introducing mut
DNMT1 reduces the expression of the DNMT1 speciﬁc
genes below levels found in the control DNMT1
 /  E1
clone, and for some genes similar to or below levels
found in parental wt HCT116 (Figure 3A). No change
in the expression of the control gene, cMYC, was
observed with introduction of either wt or mut DNMT1.
Similarly, in expression proﬁles of the 135 DNMT1 target
genes, in the wt and mut DNMT1 replacement clonal
lines, we found reduced transcripts of some target genes
in clones for both the catalytically inactive DNMT1 or the
wt DNMT1 and no distinctions could be made between
the overall expression patterns for these (Figure 3B). All
of these data suggest that putting back a catalytically
inactive DNMT1 or a wt DNMT1 have similar or indis-
tinguishable repression effects on target genes. Together,
these data are consistent with the hypothesis that there are
genes for which the catalytic activity of DNMT1 is not
required for speciﬁc gene repression.
DNA methylation is not required for gene repression
We next examined the DNA methylation status at the
promoters of four DNMT1 target genes to determine
whether this modiﬁcation was required for gene repres-
sion. All four genes have CpG islands within their
promoter region from weak to strong CpG islands
(DSCR8: CpGobs/CpGexp=0.71 to DTX3: CpGobs/
CpGexp=0.98) as characterized by the criteria of
Gardiner–Garden and Frommer and Takai et al. (31,32).
In DNMT1
 /  E1 clones, as analyzed by MSP, there is a
partial loss of DNA methylation at both the DTX3 and
TXNIP promoters (Figure 4A) while in most of the
DNMT1 wt restoration clones, the methylation is
restored. Interestingly, both DTX3 and TXNIP gene pro-
moters remained partially unmethylated when catalytic-
ally inactive DNMT1 was reintroduced (Figure 4A)
suggesting that DNA methylation was not required for
the mut protein to restore repression of these genes.
To further quantitate the DNA methylation of the
DNMT1 target genes, we performed bisulﬁte sequencing
for DSCR8, MAGEA10 and TXNIP by analyzing the
CpGs near the transcription start site. Similar to the
above MSP data, depletion of DNMT1 caused loss of
DNA methylation at all the genes studied but the degree
of loss varied from clone to clone (Figure 4B–G) ranging
from the genes being almost completely unmethylated in
E2 to retaining high levels of DNA methylation in E3. In
addition, this variability in methylation (Figure 4D–G)
correlated with the variability in expression
(Supplementary Figures S2A and B) seen in the empty
vector clones, thereby giving us conﬁdence that this was
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4338 Nucleic Acids Research, 2012,Vol.40, No. 10the right region for analysis. Restoration of wt DNMT1
caused remethylation of TXNIP (Figure 4F and G) and
some spotty remethylation of MAGEA10 (Supplementary
Figure S3) and DSCR8 (Figure 4B and C) providing
evidence that the wt DNMT1 construct has catalytic
activity. However, MAGEA10 near the transcription
start site and most of the residues in DSCR8 remained
mostly unmethylated even in the presence of wt
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and presence of methylation by ampliﬁcation in the M lanes. Bisulﬁte sequencing of (B) DSCR8,( D) MAGEA10 and (F) TXNIP. E2 and E3 are two
subclones of DNMT1
 /  hypomorph cells containing the control empty vector. Each horizontal line is an individually sequenced TA cloned allele
with each circle representing a CpG dinucleotide as distributed in the promoter region. Base pairs upstream and downstream relative to transcription
start site (TSS at 0) are numbered along the  -axis. Black circles are methylated cytosine residues, white circles are unmethylated cytosine residues.
(C, E, G) Quantitation of results as total % methylated cytosine (black bars) and % non- methylated (white bars) relative to the total number of
CpGs in the sequences.
4340 Nucleic Acids Research, 2012,Vol.40, No. 10DNMT1 (Figure 4B–4E) suggesting that, at these genes
and at these particular regions, DNA methylation is not
required for gene repression. At TXNIP (Figure 4F) and
some sites of MAGEA10 (Supplementary Figure S3) pro-
moters, the mut1 and mut2 clones containing the catalyt-
ically inactive mut showed varying levels of DNA
methylation similar to the above control empty vector
clones. Despite varying levels of DNA methylation, we
observed that mut DNMT1 repressed the expression of
both target genes below levels found in any DNMT1
 / 
hypomorph clones (Supplementary Figure S2A and B).
We, therefore, conclude that DNA methylation is not
required for gene repression of target genes demonstrating
the non-catalytic activity of the DNMT1 protein.
DNMT1 recruitment to promoters alters
histone modiﬁcations
To learn more about how the insertion of exogenous
DNMT1 into DNMT1
 /  cells may be working to
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Figure 5. DNMT1 recruitment to promoters correlates with loss of active histone marks. ChIP at DSCR8, DTX3, MAGEA10, TXNIP and MYC
promoter regions for (A) aFLAG vector (B) H3-K4me2, (C) H3-K4me3 and (D) H3-K9Ac. Samples included HCT116, DNMT1
 /  empty vector
(E1), wtDNMT1 clones (wt1 and wt2) or mutDNMT1 clones (mut1, mut2). RT–PCR was conducted and the average levels of enrichment relative to
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Nucleic Acids Research, 2012,Vol.40, No. 10 4341repress target gene promoters, ChIP for the FLAG tagged
wt and mut DNMT1 was performed. The promoter
regions of all DNMT1 responsive genes, but not cMYC,
showed an enrichment of both FLAG tagged proteins
(Figure 5A) illustrating that both the wt and mut
proteins were being recruited speciﬁcally to these genes.
In order to better understand the mechanism of
DNMT1 repression, especially in the mut replacement
clones, we mapped the chromatin changes coupled to re-
cruitment of the protein. H3-K4me2 (Figure 5B),
H3-K4me3 (Figure 5C) and H3-AcK9 (Figure 5D), all
histone modiﬁcation marks correlated with active tran-
scription, were enriched at promoters of target genes in
the DNMT1
 /  E1 clones. CMYC, however, showed a
slight decrease of H3-K4me3 mark in E1 (Figure 5C) cor-
responding to slight decrease in expression as seen in RT–
PCR (Figure 3A). With reinsertion of either wt or
mut DNMT1, the active marks were subsequently
depleted at these same promoters. Repressive marks,
H3-K9me2 (Supplementary Figure S4A), H3-K9me3
(Supplementary Figure S4B) and H3-K27me3
(Supplementary Figure S4C), however, did not consistent-
ly change with loss of DNMT1. Our data indicate that,
while loss of DNMT1 at the promoters of the genes
studied greatly inﬂuences the active histone marks with
concomitant increased expression of target genes, repres-
sive histone marks are not dramatically affected. We also
illustrate that the catalytic activity of DNMT1 is not
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4342 Nucleic Acids Research, 2012,Vol.40, No. 10required for depletion of active histone modiﬁcations
at the promoters of its target genes suggesting further,
that the protein, DNMT1, has inherent capacity for re-
pressing the expression of the target genes in a manner
distinct from the enzymatic activity associated with
DNA methylation.
DNMT1 recruits LSD1 to target promoters
We next assessed localization of enzymes which modulate
some of the dynamics observed with regard to changes in
histone modiﬁcations associated with gene expression.
One of these proteins, LSD1/KDM1A, responsible for
demethylating H3-K4me2 and H3-K4me1 (33), is known
to interact with DNMT1, but with unknown speciﬁcity for
targeting gene promoters (24). We used ChIP to examine
the localization of LSD1 to DNMT1 target genes. First,
we found that LSD1 was associated to all the promoters in
HCT116 cells above background (Figure 6A) with cMYC,
a non-DNMT1 target, having the lowest amount of
LSD1. Next, we observed that LSD1 levels at the gene
promoters were signiﬁcantly lower in the DNMT
 / 
clones than in the wt, parent HCT116 cells (Figure 6B).
With the insertion of wt DNMT1, there is a distinct and
signiﬁcant increase of LSD1 at the promoter regions of
DTX3, MAGEA10 and TXNIP (Figure 6B) and insertion
of mut DNMT1 shows a signiﬁcant increase of LSD1 lo-
calization at all the gene promoters studied (Figure 6B).
We further mapped LSD1 localization at several sites
near the transcription start sites for two genes, DTX3
(Figure 6C) and TXNIP (Figure 6D). Here, we observed
HCT116 cells as well as both wt and mut reinsertion
clones had higher levels of LSD1 localization compared
to the DNMT1
 /  cells, especially near the transcriptional
start site (Figure 6C and D).
Next, we assessed whether DNMT1 interacted with
LSD1. We found that overexpression of HA tagged
LSD1 immunoprecipitated with endogenous DNMT1
(Figure 7A). Additionally, the two endogenous proteins
could be bi-directionally immunoprecipitated by anti-
bodies against both DNMT1 and LSD1 (Figure 7B and
C) but neither protein interacted with nuclear protein CBP
(Figure 7C). In addition, LSD1 did not show any inter-
actions in the DNMT1 KO clones (Figure 7B). These
studies suggest that LSD1 is at least one protein being
recruited by DNMT1 to speciﬁc sites and, therefore,
may be responsible for the loss of H3-K4me2 which
accompanies subsequent repression of genes by the
protein.
To that end, we next examined the importance of LSD1
on gene expression at our target genes by using shRNA to
knock down the protein in wt or mut DNMT1 replace-
ment cells (Figure 8A). A general trend of increased gene
expression of some of our DNMT1 target genes after
LSD1 knockdown was observed with some variability in
the mut replacement clones (Figure 8B). This suggests that
LSD1, recruited by DNMT1, has some role in regulating
the expression of DNMT1 target genes.
DISCUSSION
Our studies show that at some endogenous gene targets,
DNMT1 can repress gene expression independent of its
catalytic function. Our work markedly extends studies
which have suggested such function but were performed
only with exogenous reporter constructs (11,14,15). In
contrast, the present work identiﬁes target genes in their
native chromatin conﬁguration. Our detailed studies of
selected target genes, coupled with our expression arrays
suggest there may be hundreds of DNMT1 target genes.
The precise number is difﬁcult to discern in our system
given the clonal variation in gene upregulation we
observed for HCT116 DNMT1
 /  cells. The small
overlap of common genes found regulated by DNMT1
may be due to the presence of a limiting amount of a
truncated DNMT1 leading to inefﬁcient and spotty
basal methylation (10). Nevertheless, the 229 genes
identiﬁed from four overlapping DNMT1
 /  subclones
provided conﬁdence that these genes were bona ﬁde
DNMT1 target genes.
Previous work has shown that DNMT1 homodimerizes
via the TS domain although the requirement for the di-
merization for DNMT1 activity has not been elucidated
(34). It may be possible that some of the effects seen at the
target genes are due to the truncated DNMT1 dimerizing
with the exogenous DNMT1. However, since we also
A
B
C
input
WT KO WT KO WT KO
DNMT1 IP LSD1 IP
L
αDNMT1
αLSD1
input
CBP MT1 CBP LSD1
IP IP
L
αDNMT1
αLSD1
HCT116
i
n
p
u
t
α
D
N
M
T
1
α
F
L
A
G
IP:
αHA
αCBP
100
130
250
100
130
250
Figure 7. LSD1 interacts with DNMT1. (A) Co-immunoprecipitation
and western blot analyses were performed in HCT116 cells
over-expressing HA-LSD1 and immunoprecipitation of anti-DNMT1
or anti-FLAG as a negative control and western blot for anti-HA.
(B) Endogenous co-IP and western blot analyses were performed in
HCT116 (WT) and DNMT1
 /  5F (KO) using anti-DNMT1 or
anti-LSD1 antibodies. (C) Endogenous co-IP using anti-LSD1
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three proteins were performed.
Nucleic Acids Research, 2012,Vol.40, No. 10 4343observed that expression of DSCR8, MAGEA10, TXNIP
and DTX3 were repressed without DNA methylation, this
supported our hypothesis that the catalytic activity is not
required for gene repression.
While our current data show that DNA methylation
is not required for the repressive action of DNMT1
upon some of its target genes, the degree of gene re-
pression in the mut DNMT1 reinsertion clones was
often a bit weaker than for that produced by the ex-
ogenous wt protein. This was also observed in previous
studies mentioned above wherein full length DNMT1
reduced transcription of the reporter gene better than
did the protein when the N-terminus was truncated
(14). Thus, both catalysis of DNA methylation and
possible scaffolding effects of DNMT1 may be
variably important for control of target genes. This is
consistent with all of our studies where, despite the
varying DNA methylation levels observed in our mut
DNMT1 clones, we still observed repression of target
genes compared to any of the DNMT1
 /  hypomorph
subclones.
Our present studies, strongly suggest that DNMT1
may have a multi-faceted function which combines both
a transcriptional repression mechanism and DNA
methyltransferase activity to provide multiple layers of
gene silencing. This is an important concept for under-
standing the full role of this protein in the basic biology
of gene expression control. There may be a wide-ranging
participation of this protein, as a corepressor, in such
regulation, even for genes that do not normally utilize
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4344 Nucleic Acids Research, 2012,Vol.40, No. 10promoter DNA methylation for control of their expres-
sion. This concept invites further investigations of the sites
at which DNMT1 functions and the types of protein
complexes in which it participates to perform these.
Those protein complexes that control a range of histone
modiﬁcations such as H3-K4me2, H3-K4me3 and
H3-K9Ac, are suggested by our studies. In addition to
interaction with H3-K4 demethylases (KDMs), inter-
actions with HDAC1 and 2 have been previously shown
(11,14,15) and these deacetylases can be components of
many repressive complexes (35,36).
In addition to the importance of complex protein inter-
actions for normal gene control, our ﬁndings have trans-
lational implications. For example, there is much interest
in DNMT1, and other DNA methyltransferases, as targets
for cancer therapy in terms of reversing abnormal gene
silencing associated with DNA hypermethylation
of promoter CpG islands (37,38). In this regard, clinic-
ally approved DNA demethylating drugs, such as
5-azacytidine and 5-aza-20deoxycytidine not only block
the catalytic function of DNMT1 but also induce its deg-
radation and depletion from the nucleus (18,19). Our
present work, then, emphasizes that alterations in expres-
sion induced by these drugs could span beyond genes
controlled by DNA methylation alone. Investigating this
possibility could broaden our concepts of how DNMT1
might be involved with, and targeted for therapy in,
diseases like cancer.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online:
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